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Introduction
Gastrointestinal absorption plays a key role in determining the efficacy of orally administered therapeutic agents. Xenobiotic transporters have recently been identified to be expressed in small intestinal epithelial cells, and are thought to be involved in membrane permeability of at least certain types of therapeutic agents (Sai and Tsuji, 2004; Herrera-Ruiz and Knipp, 2004; Thwaites and Anderson, 2007) . Several types of efflux transporters which belong to the ATP binding cassette (ABC) superfamily, including P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein, have been confirmed to play a role as a barrier against membrane permeation of therapeutic agents and xenobiotics. On the other hand, the role of influx mechanism(s) in gastrointestinal absorption of drugs has not yet been fully clarified. One reason for this may be the limited number of animal models with knockout or deficiency of genes for influx transporters expressed on apical membranes of small intestine, whereas mice with knockout of various ABC transporter genes are readily available. Most studies on the role of influx transporters have employed in vitro experimental tools, such as gene expression systems, and histochemical/biochemical analyses, such as immunostaining and western blotting.
Oligopeptide transporter PEPT1/SLC15A1 is a small-intestinal influx transporter that is thought to be involved in gastrointestinal absorption of various types of drugs, including β-lactam antibiotics. These antibiotics are usually administered orally because of their substantial DMD #23689
-6 -absorption of glucose, although only limited information is available on pharmacokinetic role of SGLT1 in the small intestine in vivo.
The small GTP-binding protein Rab8 is a member of the Rab GTPase family. The structure of Rab GTPase is well conserved from yeast to human, and the Rab GTPase family has more than 60 members in humans (Stenmark and Olkkonen, 2001; Grosshands et al., 2006) . Many Rab proteins are expressed ubiquitously in tissues and are localized at the cytosolic side of cellular membranes, being involved in intracellular vesicular transport (Stenmark and Olkkonen, 2001; Grosshands et al., 2006) . Rab8 was first cloned from a cDNA library of Mardin-Darby canine kidney cells, and has been demonstrated to be involved in protein trafficking from the trans-Golgi network to the basolateral membranes in vitro (Huber et al., 1993; Ang et al., 2003) . Sato et al (2007) recently demonstrated that the deficiency of the rab8 gene in mice leads to reduced expression and missorting of various apical membrane proteins, including PEPT1 and SGLT1 to the intracellular compartment, with minimal effects on basolateral membrane proteins in small intestine.
Uptake of substrates of these transporters, glycylsarcosine (Gly-Sar) and α-methyl-d-glycopyranoside (α-MDG), respectively, from the apical membrane was almost entirely abrogated to the background level in small intestine isolated from rab8 gene knockout (rab8 -/-) mice (Sato et al., 2007 dissolved in saline was orally administered by gavage. At various intervals up to 240 min after administration, aliquots of about 10 µL of blood were collected through the caudal vein. All blood samples were immediately centrifuged to obtain plasma. For the quantification of cefixime, the plasma samples (5 µL) were mixed with methanol (15 µL). All the mixed solutions were centrifuged at 19,000 g for 15 min at 4 °C. The supernatants were subjected to HPLC analysis. For the quantification of antipyrine, the plasma samples (5 µL) were mixed with acetonitrile (15 µL).
After the centrifugation, the supernatants were diluted with mobile phase (at a volume ratio of 1:49) and again centrifuged. The supernatants were then subjected to LC-MS/MS analysis. [ 14 C]α-MDG was determined as radioactivity associated with plasma, which was mixed with Clearsol I (Nacalai Tesque Inc., Kyoto, Japan) as the scintillation fluid. The radioactivity was determined using a liquid scintillation counter, LSC-5100 (Aloka, Tokyo, Japan).
Pharmacokinetic parameters were determined by moment analysis. Since the elimination phase in the plasma concentration profiles of cefixime and α-MDG could not be fully chased after oral administration, area under the curve (AUC) was calculated until the end of the in vivo experiment (240 min). Therefore, absolute bioavailability (BA) cannot be calculated, and the apparent BA was estimated as (AUC po, 
Uptake study in everted intestinal sac
Everted intestinal sacs were prepared from the upper part (within 10 cm below the pylorus) of the small intestine according to the reported method (Nakashima et al., 1984b Jolla, CA). Xenopus laevis oocytes were prepared and injected with 50 nL of cRNA (25 ng) or water as described previously (Terasaki et al., 1993) . Four days after the cRNA injection, the oocytes were transferred to ND96 solution (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 and 5 mM HEPES, pH 7.4). After preincubation at 25˚C for 15 min, uptake was initiated by replacing the solution with fresh ND96 solution containing 5 mM MES instead of HEPES (pH 5.0 or 6.0) and cefixime at 25°C. At the designated times, the oocytes were rinsed five times with ice-cold ND96 solution. Individual oocytes were disrupted in 35 µL of methanol with a tip sonicator, and the lysate was cleared by centrifugation at 15,000 g for 15 min at 4 °C. The supernatant was then subjected to HPLC analysis.
HPLC Analysis
The HPLC analysis was performed as described previously (Tsuji et al., 1987a (Tsuji et al., , 1987b Tamai et al., 1988) 
Measurement of antipyrine by LC-MS/MS analysis
The LC/MS/MS system was equipped with a constant flow pump (Agilent 1200 series G1312A, Agilent Technologies, Tokyo, Japan), an automatic sample injector (G1367B; Agilent Technologies), a column oven (G1316A; Agilent Technologies) and a mass spectrometer (API 3200, Applied Biosystems, Tokyo, Japan). The analytical column was COSMOSIL ® 5C18-MS-Ⅱ (2.0 mm x 50 mm; Nacalai Tesque Inc., Kyoto, Japan). Mobile phase A was 0.01 M ammonium formate and mobile phase B was methanol. The gradient elution time program was as follows: 0-1 min, B 7-70%; 1-9.5 min, B 70%; 9.5-9.6 min, B 70-7%; 9.6-19.6 min, B 7%. The flow rate was 0.2 mL/min. Separation was performed at 40 °C. The multiple reaction monitor was set at 189.2 to 56.0 m/z for antipyrine.
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RESULTS
Intestinal absorption of cefixime and α-MDG was reduced in vivo in rab8 -/-mice
Since the expression and apical localization of PEPT1 and SGLT1 were reduced in small intestine of rab8 -/-mice, compared with wild-type mice (Sato et al., 2007) , we hypothesized that oral absorption of cefixime and α-MDG would be decreased in rab8 -/-mice, if PEPT1 and SGLT1, respectively, are responsible for gastrointestinal absorption of these compounds. In the present study,
we first compared oral absorption of cefixime between wild-type and rab8 -/-mice. Plasma concentrations of cefixime after oral administration in rab8 -/-mice were lower than those in wild-type mice (Fig. 1A) , the AUC po,0-240 in rab8 -/-mice being 40% of that in wild-type mice (Table   1) . Further, when cefixime was intravenously injected, both AUC and distribution volume (V dss )
were similar in the two strains, suggesting that distribution and systemic elimination are not very different in these strains (Table 1) .
The plasma concentration profile of α-MDG was next examined in wild-type and rab8 -/-mice after oral and intravenous administrations. Plasma concentrations of α-MDG after oral administration in rab8 -/-mice were higher than those in wild-type mice (Fig. 1B) , the AUC calculated from 0 to 240 min in rab8 -/-mice being lower than that in wild-type mice (Table 1 ). The apparent BA in rab8 -/-mice was 40% of that in wild-type mice (Table 1) . On the other hand, oral absorption of antipyrine, membrane permeation of which is not transporter-mediated, was also examined as a control study. Plasma concentrations of antipyrine after oral administration in rab8 -/-mice were slightly, but significantly higher than those in wild-type mice (Fig. 1C) .
Uptake of cefixime from apical membranes was reduced in small intestine of rab8 -/-mice
To confirm the change in the membrane permeability of cefixime in the apical membrane of small intestine in rab8 -/-mice, everted sacs were prepared from both wild-type and rab8 -/-mice, and the uptakes of cefixime were compared. Uptake of cefixime in wild-type mice was significantly higher than that in rab8 -/-mice, and was decreased in the presence of 20 mM unlabeled Gly-Sar ( Fig. 2A, 2B ). The uptake in the presence of Gly-Sar in wild-type mice and that in rab8 -/-mice (~ 0.2 µL/mg protein/15 min) were close to the apparent uptake of an extracellular marker, mannitol (Fig. 2B, 2D ). Decreased uptake from apical membrane of rab8 -/-mice was also observed for another β-lactam antibiotic, cephalexin (Fig. 2C ).
Since the driving force of PEPT1-mediated uptake is a proton gradient, the pH dependence of cefixime uptake was next examined in small intestines of both strains. The uptake of cefixime in wild-type mice was higher at lower pH values, whereas that in rab8 -/-mice did not exhibit pH dependence (Fig. 3) and was close to the apparent uptake of mannitol (Figs. 2D, 3 ). Such a pH profile is similar to our previous observation in the uptake of cefixime by brush-border membrane vesicles of rat small intestine (Tsuji et al., 1987b) .
Cefixime is a substrate of mouse PEPT1
Cefixime is known to be transported by human, rabbit and rat PEPT1 in vitro (Wenzel et al., 1996 , Ganapathy et al., 1997 Tamai et al., 1997) , but there has been no direct demonstration that cefixime is transported by mouse PEPT1. In the present study, mouse PEPT1 was cloned, and cRNA of the mouse PEPT1 was injected into Xenopus laevis oocytes. The cefixime uptake by oocytes injected with cRNA for mouse PEPT1 was 54.2 ± 10.4 nL/oocytes/90 min (mean ± S.E.M., n = 10-11 oocytes), whereas that by water-injected oocytes was under the determination limit (< 0.5 nL/oocytes/90 min). These cefixime uptakes were decreased in the presence of 20 mM unlabeled Gly-Sar to the level under the determination limit.
This article has not been copyedited and formatted. The final version may differ from this version. et al., 2007) , and therefore, should be suitable to demonstrate the role of the transporter in drug absorption. In the present study, the uptake of cefixime from the apical side of small intestine isolated from rab8 -/-mice was found to be quite small ( Fig. 2A) . Indeed, it could mainly represent nonspecific adsorption of cefixime, since the absolute value of the uptake was similar to that of mannitol ( Fig. 2A, 2D ). The uptake of cefixime in wild-type mice was inhibited by the dipeptide Gly-Sar and depended on the extracellular pH value, but that in rab8 -/-mice was not inhibited by Gly-Sar and was pH-independent (Figs. 2D, 3) . These results are consistent with the observation that oral absorption of cefixime was much lower in rab8 -/-mice than in wild-type mice (Fig. 1A , Table 1 ). Because cefixime is not metabolized in the body and is mainly excreted in urine in unchanged form (Sakamoto et al., 1985) , the decrease in AUC po,0-240 and apparent BA values (Table 1) Similar down-regulation was also reported for another small intestinal nutrient transporter, et al., 2007) . Therefore, the oral absorption of SGLT1 substrate α-MDG was also examined in the present study, and was found to be decreased in rab8 -/-mice (Fig.   1B , Table 1 ). However, gastrointestinal absorption of both cefixime and α-MDG was not completely blocked in rab8 -/-mice (Fig. 1A, 1B) ; the apparent BA values for both compounds in rab8 -/-mice remained as high as 40% of those in wild-type mice (Table 1) . Thus, rab8 gene deficiency alone does not result in complete loss of absorption of these compounds. One possible explanation may be that small numbers of PEPT1 and SGLT1 molecules, which could not be detected in the previous immunohistochemical analysis ( Sato et al., 2007) , are still present in apical plasma membranes and are involved in membrane permeation of these compounds in rab8 -/-mice.
Even a small amount of PEPT1 or SGLT1 present in the small intestine could be enough to mediate significant absorption of these compounds during their movement inside the gastrointestinal tract.
Another possible explanation may be increased passive diffusion through the intestinal membranes of rab8 -/-mice, since oral absorption of antipyrine, the membrane permeation of which is thought to represent passive diffusion, was slightly higher in rab8 -/-mice than in wild-type mice (Fig. 1C) .
This article has not been copyedited and formatted. The final version may differ from this version. The rab8 -/-mutation is lethal, and therefore, rab8 -/-mice at 20 days after birth were used in the present study. At this time, small intestines of rab8 -/-mice were swollen and longer than those in wild-type mice. Such morphological changes in the small intestine of rab8 -/-mice may be relevant to the change in antipyrine absorption. An increase in passive diffusion would lead to underestimation of the contribution of PEPT1 and SGLT1 to the overall absorption of cefixime and α-MDG, respectively, in the present study. The developmental changes in expression of PEPT1 after birth in rodents may also be relevant to the estimation of the contribution of PEPT1. Limited information is available on developmental changes in PEPT1 expression in mouse small intestine, whereas the expression level of PEPT1 in rat small intestine is known to increase biphasically: it increases within 1 week after birth and, then after a transient decrease, it gradually increases again from two to 4 weeks after birth (Miyamoto et al., 1996; Shen et al., 2001 ). Therefore, the expression level of PEPT1 at 20 days could be lower than the adult level, and this may lead to underestimation of the contribution of PEPT1.
We recently proposed that both PEPT1 and carnitine/organic cation transporter In the present study, gastrointestinal absorption in vivo and uptake from the apical membrane of isolated small intestine in vitro of cefixime were examined and found to be much smaller in rab8 -/-mice, compared with wild-type mice. Gastrointestinal absorption of α-MDG in rab8 -/-was also lower than that in wild-type mice. It is concluded that PEPT1 and SGLT1 are involved in the gastrointestinal absorption of these substrates in vivo, if we consider the mislocalization and reduced expression of PEPT1 and SGLT1 in rab8 -/-mice.
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